Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast Asia
Clinical Infectious Diseases2010Vol. 51(11), pp. e82–e89
Citations Over TimeTop 1% of 2010 papers
Harald Noedl, Youry Se, Sabaithip Sriwichai, Kurt E. Schaecher, Paktiya Teja‐Isavadharm, Bryan Smith, Wiriya Rutvisuttinunt, Delia Bethell, Sittidech Surasri, Mark M. Fukuda, Duong Socheat, Lon Chan Thap
Abstract
ClinicalTrials.gov identifier NCT00479206.
Related Papers
- → From Artemisinin to New Artemisinin Antimalarials: Biosynthesis, Extraction, Old and New Derivatives, Stereochemistry and Medicinal Chemistry Requirements(2006)222 cited
- → Is Artemisinin the Only Antiplasmodial Compound in the Artemisia annua Tea Infusion? An in Vitro Study(2013)19 cited
- Effect of Development Stage on the Artemisinin Content and the Sequence Characterized Amplified Region （SCAR） Marker of High-Artemisinin Yielding Strains of Artemisia annua L.(2006)
- Artemisia annua glandular secretory trichomes： the biofactory of antimalarial agent artemisinin(2016)
- Research achievements in the synthetic biology and metabolic engineering of artemisinin(2011)